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SUlTllnary 
Naive T  cells are selectively recruited from the blood into peripheral lymph nodes during lym- 
phocyte recirculation. L-selectin, a lectin-like receptor, mediates the initial attachment oflym- 
phocytes to high endothelial venules (HEV) in lymph nodes. A subsequent step involving the 
activation of {32 integrins has been proposed to facilitate firm adhesion, but the activating sig- 
nals are poorly understood.  We report here that either antibody-mediated cross-linking of 
L-selectin on human lymphocytes or treatment of the ceils with GlyCAM-1, an HEV-derived, 
secreted ligand  for L-selectin,  stimulates  their binding  to  ICAM-1  through  the  {32  integrin 
pathway. Furthermore, GlyCAM-1 causes the rapid expression ofa neoepitope on {32 integrins 
associated with  a high-avidity state.  Naive  (CD45RA+),  but not memory (CD45P,.0 +)  lym- 
phocytes, respond to L-selectin cross-linking or GlyCAM-1 treatment. Thus, the complexing 
of L-selectin by specific ligands may provide key signals  to naive lymphocytes, contributing to 
their selective recruitment into peripheral lymphoid organs. 
T 
he  widely  accepted  cascade  model  of leukocyte  re- 
cruitment from the blood (1, 2) proposes that selectins 
mediate  tethering  and rolling of leukocytes along the  en- 
dothelium. Leukocyte integrins,  upon rapid activation, are 
responsible for slowing and arresting the  cells  through in- 
teractions with specific counter-receptors displayed on the 
endothelium.  Arrest is followed by diapedesis into the tis- 
sue.  In the case of lymphocyte homing to lymph nodes, 
L-selectin on the lymphocytes mediates the initial tethering 
and  rolling  of the  cells  along  the  specialized  endothelial 
cells of HEW  (3, 4).  LFA-1  (otLI32) appears to be the most 
relevant integrin,  since  specific rnAbs against otL[32 effec- 
tively block lymphocyte migration  to  LN  (5,  6)  and  the 
ICAM  counter-receptors  are  expressed  on  LN  HEV  (7). 
An unsolved problem is the identity and nature of the sig- 
nals  (possibly chemokines) that are responsible for the trig- 
gering  of o~Li32 from a  conformation  or  distribution  that 
manifests  weak  affinity for the  ICAMs  to  a  high  affinity 
state (8, 9). 
GlyCAM-1 (10,  11), in contrast to the two other molec- 
ularly described HEV-ligands for L-selectin (MAdCAM-1 
i Abbreviation used in this  paper: HEV, high endothelial venules. 
and CD34),  is a secreted protein with no known associa- 
tion with the endothelial surface (12).  It is present in mouse 
serum at a concentration  of'-'1.5 Ixg/ml and the  isolated 
molecule  retains  L-selectin  binding  activity  (11).  These 
characteristics raised the possibility that GlyCAM-1  might 
serve  as  a  soluble  signaling  molecule  acting  through  cell 
surface L-selectin. In the present study, we show that liga- 
tion of L-selectin via either GlyCAM-1 or antibody cross- 
linking  enhances  {32  integrin  function  in  naive,  but  not 
memory, T  cells. 
Materials  and Methods 
Antibodies and Cells Lines.  mAb24 (mouse IgG  0 was a kind gift 
of Dr. N. Hogg (Imperial Cancer Research Fund, London, UK). 
E3 is a mouse melanoma cell line transfected with human ICAM-1 
and was provided by Dr. L. Graf, Jr.  (University of Chicago,  IL) 
(13). IB4  (mouse  IgG~) was a gift of Dr.  T.  Tednock (Athena 
Neurosciences,  S. San Francisco, CA). Humanized DREG55 and 
DREG200 mAbs (human IgG4) were generously provided by Dr. 
E. Berg (Protein Design Labs, Mountain View,  CA), and mouse 
DREG55 and DREG56 mAbs (IgG1) were donated by Dr. T.K. 
Kishimoto (Boehringer-Ingelheim,  Ridgefield,  CT). 
Other  mAbs  used  were  18D3  and  TS1/6  (Endogen,  Cam- 
bridge,  MA)  and  anti-CD45RA/RO  (K.  Soo,  DNAX  Corp., 
Palo Alto, CA). 
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serum as described by Singer and Rosen  (11).  The yield of Gly- 
CAM-1  was ~0.5  Ixg per ml of starting serum.  GlyCAM-1 thus 
isolated was  >98%  pure  as  deternfined  by  amino-terminal  mi- 
crosequencing and Coomassie staining. 
Adhesion Assays.  Human mononuclear cells were isolated from 
normal  adult  volunteers  by  centrifugation  of  Heparinized  or 
EDTA-treated venous blood over Histopaque 1077 (Sigma Chem. 
Co., St. Louis, MO). After washing in cold Buffer A (Ca2+/Mg  2+ 
Free Hank's  Balanced  Salt Solution with  0.125%  human  serum 
albumin),  peripheral  blood lymphocytes  (PBL)  were isolated by 
negative selection with anti-CDl 4 (monocyte) coupled magnetic 
beads (Dynal, Lake Success, NY). Typically, >95% ofmonocytes 
could  be  removed  from  the  mononuclear  cells  as  detected  by 
size/granularity parameters in a flow cytometer. Memory and na- 
ive populations were isolated by appropriate incubation with anti- 
CD45RO,  anti-CD45RA,  anti-CD19  (t3  cell),  and  anti-CD14 
mAbs  (Caltag,  South San  Francisco,  CA) for 30 rain  on ice fol- 
lowed by negative selection using sheep  anti-mouse  IgG-coated 
magnetic beads (Dynal). Typically, 95% ofmonocytes and 97% of 
B  cells were removed by  this  method.  After isolation,  lympho- 
cytes  were  labeled  with  BCECF/AM  (Calbiochem-Novabio- 
chem,  La Jolla, CA) (14)  for 25 min at 37~  before further treat- 
ment  as  detailed in  the  figure legends.  75  fxl of cells  (10  s  cells) 
were transferred  to  triplicate wells of a  96-well plate  containing 
confluent E3 cells and allowed to settle for 20 rain at 22~  before 
stitnulation.  After stimulation  (see  figure legends)  for 20  rain  at 
37~  the plates were washed four times with Buffer B  (Buffer A 
plus  0.6  mM  Ca2+/0.2  mM  Mg  2+)  and  cell binding  was  mea- 
sured with a Millipore Cytofluor fluorescence plate  reader.  Un- 
less otherwise indicated, the error bars shown in the figures repre- 
sent  the  standard  errors  of  the  mean  (SEM)  based  on  three 
determinations. All experiments were repeated at least three times 
with different blood donors.  The  data  shown  are  representative 
results from one donor. 
For cross-linking studies  (Figs.  l  and 6),  total (unfractionated), 
nlemory,  and  naive T  lymphocytes were isolated and  labeled as 
described above. In Fig.  1, unfractionated T  cells were either un- 
treated or treated with 5 pxg/ml humanized (lgG4)  anti-L-selectin 
nLAb with low affinity for human  Fc receptors (DREG55,  refer- 
ence 15) at 22~  for 20 min in buffer A. In Fig. 6, total, memory, 
and naive lymphocytes were treated with 2.5 txg/ml biotinylated 
humanized  DREG200  at 22~  for 20  rain  in buffer A.  In both 
experiments,  the  treated  cells were  pelleted and  resuspended  in 
Buffer B  (Buffer A  +  0.6  mM  Ca2+/0.2  mM  Mg  2+)  to  a  final 
concentration of 1.3  X  1()  ~ cells/ml and then distributed to wells 
as  described  above.  To  achieve  conventional  cross-linking,  a 
cross-linking goat F(ab')2 anti-human  IgG (Fig.  l)  was added to 
the indicated final concentration  (Ixg/ml).  For cross-linking of a 
biotinylated L-selectin mAb (DREG200), avidin was added at the 
indicated concentrations  (see  Fig.  6).  Data  are  expressed as per- 
cent of cells bound relative to the total number of cells added. 
How Cytometry.  For real-time measurement ofmAb24 bind- 
ing (16),  5  ￿  1l)  s PBL (isolated as above) in 200 la,1 buffer B were 
preincubated with 15  btg/ml Cy3-conjugated mAb24 for 1() rain 
at 22~  Cells were  warmed  to  37~  and  stinmlant  was  added 
immediately at time zero.  Samples were continuously nfixed and 
drawn  into  a  Becton-Dickinson  FACScan  |  3,000  events were 
collected in 10 s for each time point. 
Cell surface staining was performed on the isolated populations 
with  FITC-conjugated  anti-L-selectin  (DREG56,  0.3  btg/ml; 
Inmmnotech),  anti-CD45RA  (MEM56,  4  Izg/ml; Caltag),  anti- 
CD45RO  (UCHL1, 4 ~g/m]; Caltag), or anti-CD18 (MEM48, 
4  btg/ml;  Caltag)  antibodies  at the  indicated  concentrations  and 
analyzed  by flow cytometry.  Sinfilar staining  patterns  were  ob- 
served with at least five different donors using two different anti- 
bodies for L-selectin and CD 18. 
For routine  mAb24 binding assays (see  Fig.  5),  isolated  naive 
and memory T  cell lymphocyte populations were resuspended in 
buffer B at 1.0  X  10  s cells in 50 Ixl buffer containing either 1 Ixg/ml 
FITC-mAb24  or  non-immune  class-matched  FITC-IgG I  (Cal- 
tag)  as  a  control  for  nonspecific  binding  of lgG  to  cells.  GIy- 
CAM-1 or PMA was added to the indicated final concentrations 
for  20  nfin  at  37~  After pelleting,  the  cells were  then  resus- 
pended  in  50  Ixl buffer  B  containing  20  Ixg/ml  rabbit  F(ab')2 
anti-mouse IgG (Zymed, South San Francisco, CA) fbr 10 rain at 
22~  to stabilize the mAb24 signal, which tended to decrease in 
the absence of the stimulus.  For flow cytometric analysis,  the cells 
were pelleted and resuspended  in buffer B.  mAb24-positive cells 
(>1{)  fluorescence  units)  are  defined  as  cells exhibiting fluores- 
cence above that observed with unstimulated  PBL stained with a 
FITC-IgG I isotype control antibody.  Control  FITC-IgG~  bind- 
ing in the presence of GlyCAM-1 or PMA was the same as in un- 
stinmlated cells. 
Results  and  Discussion 
Previously,  Simon  et  al.  (16)  demonstrated  that  anti- 
body-mediated  cross-linking  of L-selectin  on  neutrophils 
upregulates  the function  of the  ]32  integrin,  Mac-1  (o~M]32). 
We asked whether cross-linking L-selectin on lymphocytes 
could  also  stimulate  adhesion  through  a  [32  integrin  path- 
way. As shown in Fig.  1,  treatment  of human  PBL with an 
L-selectin  mAb  plus  a  secondary  cross-linking  antibody 
stinmlated adhesion  to ICAM-I  transfected melanoma cells 
about  twofold.  The  stimulated  adhesion  was  blocked  by a 
~2-specific mAb but not by a function-blocking,  ]31-directed 
mAb.  Treatment  of lymphocytes  with  the L-selectin mAb 
alone or the cross-linking antibody had no effect. 
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Figure  1.  Cross-linking  L-selectin  stimulates  adhesion  of" peripheral 
blood lymphocytes  to ICAM-1. Peripheral blood lymphocytes were iso- 
lated,  labeled,  and  treated  with  humanized  anti-L-selectin  antibodies 
(Anti-L-sell in an adhesion  assay as described  in Materials and  Methods. 
Where indicated,  lymphocytes  were pretreated  for 10 rain  at 22~  with 
either  10  Ixg/ml  anti-132 antibody  (anti-B2)  (TS1/16)  or  a  function 
blocking anti-131 antibody (anti-B1) as a control (181)3) before adding the 
cross-linking antibody  (XL, in Ixg/ml). Cross-linking  had no ef}'ect  when 
untransfected melanoma cells were used as the substratum (not shown). 
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Figure  2.  GlyCAM-1 stimulates the adhesion of peripheral blood lym- 
phocytes to ICAM-1 in an L-selecfin and 82 integrin dependent manner. 
Human PBLs were isolated, labeled with BCECF/AM, and used in an 
adhesion assay as described in Materials and Methods. Cells were pre- 
treated (where indicated) with  10 p.g/ml of either a function-blocking 
an~i-iB2 antibody (anti-B2, IB4) or a funcvion-bIocking humanized anti- 
L-selectin antibody (anti-L-sel, DREG55) for 10 rain at 22~  before add- 
ing stimulants. Pretreatment with an anti-131 antibody did not block Gly- 
CAM-1 stimulated adhesion (not shown), Phorbol 12-myristate 13-acetate 
(PMA) was used at final concentration of 100 nM. GlyCAM-1 was added 
to 4 Ixg/ml. GlyCAM-1  did not stimulate lymphocyte binding to the 
non-transfected melanoma line. 
To determine whether a physiologic ligand of L-selectin 
could  also  stimulate  adhesion  to  ICAM-1,  we  employed 
GlyCAM-1  purified from mouse  serum  (11).  GIyCAM-1 
cross-reacts with human  L-selectin, since preincubation of 
PBL with 4  ~g/m] of the ligand blocked 90% of the bind- 
ing of a  FITC-labeled L-selectin mAb (DKEG56)  but not 
that of a control mAb (Leu4). 
As  shown  in  Fig.  2,  GlyCAM-1  stimulated the  adher- 
ence of unfractionated human PBL to ICAM-1 transfected 
melanoma cells to the same extent as a phorbol ester. Pre- 
treatment  of the  cells with  an  L-selectin mAb specifically 
blocked the  stimulation by GlyCAM-1  while  minimally 
affecting  PMA-stimulated  binding.  Both  the  PMA-  and 
GlyCAM-l-stimulated adhesion of PBL to ICAM-1  were 
strongly inhibited by a ~32-specific mAb but not by an anti-~l 
specific mAb (not shown). Thus,  antibody cross-linking of 
L-selectin  or  GlyCAM-1  stimulates  ~32-dependent  adhe- 
sion  of lymphocytes  to  the  endothelial  counter-receptor, 
ICAM-1. 
mAb24  recognizes  a  ~2  integrin  neoepitope  associated 
with high-affinity ligand binding (16, 17). In a real-time as- 
say,  GlyCAM-1  rapidly  increased  the  expression  of the 
mAb24 neoepitope on PBL (Fig. 3), while the binding of a 
conventional 132  mAb was  not  affected (not shown).  The 
response was detected at 30 s, the earliest time point exam- 
ined.  The  kinetics  of the  neoepitope  induction  by  Gly- 
CAM-1 paralleled those seen with manganese, a direct inte- 
gnn activator (17). The GlyCAM-1 response was abolished 
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GlyCAM-1  rapidly upregnlates expression of the  mAb24 
neoepitope associated  with j32 integnn activation_  CelJs were warmed to 
37~  and stimulant added just after time zero (Mn  2., 3 raM, ￿9  or Gly- 
CAM-I, 2.5 p,g/ml, II). In the blocking studies, the L-selectin mAbs 
DREG200  (A) and DREG56  (X) were preincubated with the cells for 
10 rain before the addition of GlyCAM-1. Data are expressed as the per- 
cent mAb24 expression at a given time point relative to unstimulated cells 
at time zero for each experimental condition (set at 100%). In the absence 
of stimulation, the mAb24 signal remained at the t =  0 control baseline 
level (not shown). 
by pretreating the PBL with L-selectin mAbs, Desialylated 
GlyCAM-1  was  unable  to  stimulate  the  mAb24  epitope 
(not shown), thus demonstrating the critical importance of 
carbohydrates for the activity of GIyCAM-1 (18). Finally, a 
dot-plot  analysis showed  that  only  a  portion  of the  total 
lymphocytes increased binding of the rnAb24  antibody in 
response to GlyCAM-1  (not shown), which suggested that 
a  subpopulation  of lymphocytes  was  responsive  to  Gly- 
CAM-1. 
Naive T  cells are preferentially recruited into peripheral 
lymph nodes from the blood (21)  compared to memory 
T  cells. To determine whether there might be a differential 
response of naive vs. memory T  cells to L-selectin ligation, 
we  isolated  these  populations  of T  cells  from  peripheral 
blood based on  their expression  of CD45KA  (naive)  and 
CD45RO  (memory) (Fig. 4). The isolated populations were 
either  uniformly CD451KA  hi or CD45RO hi  and  exhibited 
distinct  integrin  profiles.  The  CD451KO hi  population  was 
divided  into  two  equal  populations  of  L-selectin  hi  and 
L-selectin  ]~  cells, while naive lymphocytes were 60-80% 
L-selectin  hi  and  20-40%  L-selectin  l~  At  a  concentration 
(1.5  ~.g/ml)  which  approximated its mean  systemic level 
(11), GlyCAM-1 did not affect mAb24 binding. However, 
at 6 and 15 Ixg/ml, GlyCAM-1 significantly augmented the 
mAb24  epitope on naive cells, producing a  2.5X  increase 
in  the  number  of positive cells (Fig. 5).  In an  experiment 
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Figure  4.  L-selectin,  CI)18,  and Cl)451LA/RO  surface staining on 
isolated memory and naive T cells. Lymphocyte populations were isolated 
and stained with  (a)  anti-L-selectin, (b)  anti-C1)18,  (c)  anti-Cl)45P.A 
(dashed lines)  and anti-C1)451LO (solid lines)  as described in Materials and 
Methods. Unstained cells or cells stained with an irrelevant class-matched 
control antibody had an average fluorescence of 4-5 fluorescence  units on 
the scales  shown. 
with  a  different donor,  GlyCAM-I  at  9  Ixg/ml enhanced 
the percent positive cells by 3.5￿  (from 20-70%),  whereas 
at 3  Ixg/ml, an intermediate degree of stimulation was seen 
(45%  positive cells).  In contrast,  memory cells exhibited a 
higher  basal  level  of mAb24  expression,  but  were  com- 
pletely  refractory  to  stimulation  by  GlyCAM-1  (Fig.  5). 
hnportantly,  both  populations  of cells were  responsive  to 
PMA or manganese (see Fig. 5 legend), establishing that the 
~32 integrins on memory cells could be activated by other 
stimuli.  Although  NK  cells  (,-~  of peripheral  blood 
lymphocytes) were  not  specifically removed by our isola- 
tion technique,  they could not, by themselves, account for 
a  significant proportion  of the  mAb24  response  to  Gly- 
CAM-1  since we have  observed up  to  70%  of naive lym- 
phocytes responding to GIyCAM-1. We cannot, however, 
formally exclude the possibility that NK cells partially con- 
tribute to the GlyCAM-1 response in our assays. 
Consistent  with  these  neoepitope  studies,  cross-linking 
of L-selectin  via  antibodies  stimulated  adhesion  of naive 
cells by 3-fold to  the ICAM-1  substratum,  whereas mem- 
ory  cells  showed  no  response  (Fig.  6).  Cross-linking  of 
CD5  using biotinylated anti-CD5  antibodies by this tech- 
nique did not lead to enhanced adhesion compared to anti- 
body-treated cells alone. Thus, the activation of [32 integrins 
produced by ligation of L-selectin with either antibodies or 
GlyCAM-1 occurs preferentially on naive cells. 
Previous  studies have  explored the physiological factors 
that  might  activate  LFA-1  on  intravascular lymphocytes. 
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Figure  5.  GlyCAM-I enhances the  expression of the  mAb24 neo- 
epitope on naive, but not memory, T lymphocytes. Isolated lymphocyte 
subpopulations were treated with GIyCAM-I, PMA, and Mn  2§  in the 
presence of FITC-mAb24  as described in Materials and Methods. The 
cells were gated by forward and side scatter parameters and then analyzed 
for FITC fluorescence. Data is shown as percentage of mAb24-positive 
cells (see Materials and Methods for definition) in the presence of an in- 
creasing concentration of GIyCAM-1 for naive (El) and memory (A) T 
cell populations. PMA stinmlation resulted in the conversion of naive T 
cells to 88% positive (mean channel fluorescence [MCF] =  18) and of 
memory T cells to 94% positive (MCF = 35). Mn  2§ stimulation resulted 
in the conversion of >95% of both memory and naive cells with MCF of 
274 and 271 units, respectively. 
However,  the  results have  been  conflicting (20,  21).  One 
study (20) found that several chemokines can augment PBL 
adhesion  to  ICAM-1,  but  the  time  periods  of the  assay 
were  relatively long  (>15  min).  Another  study  failed  to 
observe chemokine stimulation of PBL binding to ICAM-1 
under a variety of assay conditions (21). 
The present results demonstrate that GlyCAM-I satisfies 
a  number  of important criteria for an intravascular trigger 
of lymphocyte integrins: (0 it is synthesized by the special- 
ized endothelial cells of HEV and is secreted into the blood 
(10-12);  (ii)  it activates [32 integrins within seconds,  com- 
patible  with  a  lymphocyte's limited  transit  time  through 
HEV  (2);  (iii)  the activation is selective for naive lympho- 
cytes, providing a potential explanation of their preferential 
recruitment  into  lymph  nodes.  The  multivalency of Gly- 
CAM-l,  intrinsic to its mucin-like structure  (22),  may ex- 
plain  why  it  is  active  without  additional  cross-linking, 
while the L-selectin mAbs require a second antibody. 
GlyCAM-1  is detectable in LN and  Peyer's patch HEV 
(10) and in HEV-like vessels induced at sites of chronic in- 
flammation  (23).  Thus,  the  integrin  triggering  effects  of 
GlyCAM-1  or potentially of other HEV-associated ligands 
for L-selectin (CD34,  MAdCAM-1,  Sgp200)  (22)  may be 
pertinent at multiple sites of leukocyte trafficking. A previ- 
ous  study in  a  parallel plate flow chamber failed to  detect 
activation of LFA-1 on PBL that were rolling on surface of 
immobilized  "peripheral  lymph  node  addressin"  (mixed 
population of HEV-ligands from human  tonsils) (24).  Thus, 
the ligation of a small percentage of the L-selectin at focal 
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Cross-linking L-selectin stimulates the adhesion of naive, but 
not memory lymphocytes, to ICAM-1. Isolated lymphocyte populations 
were  labeled, treated  with  biotinylated  anti-L-selectin  antibody,  and 
cross-linked with varying concentrations ofavidin as described in Materi- 
als and Methods. There was no effect of DREG200  treatment alone on 
adhesion (not shown). Error bars indicate half-range variation for dupli- 
cate determinations. 
sites of adhesion may not be sufficient to  activate LFA-1, 
whereas the more global effects of soluble GlyCAM-1  on 
the  entire lymphocyte surface  are activating.  It should be 
noted that all of our effects were seen at a concentration of 
3  ~g/ml or higher of GlyCAM-1  (2 ￿  serum levels) which 
is predicted to ligate the majority of cell surface L-selectin 
based on competition of DREG56 binding (see above). 
GlyCAM-1 has been reported to be down-modulated in 
draining LN (mouse) after antigen challenge (25). In sheep, 
antigen stimulation of LN results in a  dramatic increase in 
memory T  cell recruitment, which correlates with VCAM-1 
induction on  HEV  (26).  Thus  GlyCAM-1  may be a  spe- 
cific  modulator  of naive  lymphocyte  migration  into  LN, 
whereas  after vigorous antigen  challenge,  other triggering 
molecules (perhaps affecting [31 integrin function) (27) may 
furnish the signals for memory celt entry (26). 
Several  studies  have  demonstrated  signal  transduction 
functions for L-selectin in leukocytes (16, 28-30),  induced 
by  antibody  cross-linking or  artificial carbohydrate-based 
ligands.  This report provides the first evidence that a phys- 
iologic  L-selectin ligand  can  affect  integrin  activity on  a 
subset of lymphocytes and provides a plausible mechanism 
to  explain the selective recruitment of naive vs.  memory 
T  cells to peripheral LN. The mechanisms of rapid integrin 
triggering through an L-selectin pathway, now documented 
for both neutrophils and lymphocytes, remain to be eluci- 
dated. 
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